Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation.
about
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scalePositron Emission Tomography (PET) in OncologyPrognostic Value and Clinical Impact of (18)FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy.Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study.International Pediatric Non-Hodgkin Lymphoma Response Criteria.Burkitt lymphoma: staging and response evaluation.18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell LymphomaSurveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology GroupFDG-PET/CT based response-adapted treatment.Emerging drugs for Hodgkin's lymphoma.Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010.PET/CT adapted therapy in Hodgkin disease: current state of the art and future directions.FDG PET/CT in children and adolescents with lymphoma.Role of PET in lymphoma.The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of (18)FDG-PET/CT according to ΔSUVmax, Deauville 5-point scale and IHP criteria.The predictive value of interim and final [18F] fluorodeoxyglucose positron emission tomography after rituximab-chemotherapy in the treatment of non-Hodgkin's lymphoma: a meta-analysis.Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma.Interpretation and validation of interim positron emission tomography in Hodgkin lymphoma.qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma.Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010.Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival.Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.
P2860
Q33696003-B290A093-48DF-47F6-8297-04FFE7C17DEEQ34774840-5BE3BB87-ED41-4AD8-BB5C-DC737F3A3333Q34931319-A7276D45-59EE-48B8-B0DB-5CC6AA9A39D6Q34993792-190304D5-3204-4F30-B6EC-C1CDAE03682FQ35708769-019FA48A-F507-4BBA-B26D-1A231AAF7071Q35798945-729304A5-A58C-405A-A8C1-115CB3F4033BQ35855599-49DA5877-9939-4023-8031-CEC3B97F93BDQ36025958-71B59C5E-5C24-42CC-AAD5-94F67503B896Q36286595-7244218F-6B43-45A5-AA37-DE576E9CB07AQ37772513-072E905F-26B5-4D5F-B5D1-9EC7AD86D216Q37857870-AB38E495-6364-4F90-AE99-035249CF86AAQ38018865-FEECBB44-F2BD-4867-B89E-E192F46F973DQ38092706-AA2168CD-4A8C-4DE5-8A36-C6C64606B02CQ38195220-66512581-1381-4BC2-939A-66F57BC76CC5Q38365591-73112346-047C-4545-8AC0-FE8643D09712Q38389152-2A41BB9B-3811-4EA9-B429-9EA82F2C6A9EQ38663136-3BFFC86B-66F7-4882-AC79-61801C6893F3Q42033589-8190BF92-ED78-4CEE-B872-E30670AF6BC4Q42739969-66A3173D-9D07-4F92-870B-97F1A55CA4D3Q43168904-015DE021-4B4C-443B-A916-A47C4ECEE58EQ44307668-BC7B5912-EBE3-4968-AFC5-3420F43CEA86Q53056812-1FF4BA6B-357D-476C-B28C-DA33D57181B9Q53164168-6033028F-1CF8-45EA-8A12-1363C6C43907Q53235861-19934AC9-5BCC-4037-80CF-E0DC78686494Q53245208-F42444FD-AA29-457C-99D6-876476D2700B
P2860
Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Interim positron emission tomo ...... ules, and clinical validation.
@en
Interim positron emission tomo ...... ules, and clinical validation.
@nl
type
label
Interim positron emission tomo ...... ules, and clinical validation.
@en
Interim positron emission tomo ...... ules, and clinical validation.
@nl
prefLabel
Interim positron emission tomo ...... ules, and clinical validation.
@en
Interim positron emission tomo ...... ules, and clinical validation.
@nl
P2093
P2860
P1433
P1476
Interim positron emission tomo ...... ules, and clinical validation.
@en
P2093
Andrea Gallamini
Francesca Fiore
Michel Meignan
Roberto Sorasio
P2860
P304
P356
10.3109/10428190903308072
P577
2009-11-01T00:00:00Z